Navigation Links
Case Western Reserve University receives $1.66m grant from NIH for otoprotection research
Date:4/13/2009

CLEVELAND April 13, 2009 Qing Yin Zheng, M.D., assistant professor of Otolaryngology-Head and Neck Surgery and Genetics at the Case Western Reserve University School of Medicine, and member of the Case Comprehensive Cancer Center, has been awarded a five year $1.66 million grant from the National Institutes of Health (NIH) Research Project Grant Program (R01) to explore the impact of several molecular pathways on inner ear dysfunction in Ushers syndrome.

Usher Syndrome (USH) is a clinically and genetically heterogeneous disorder characterized by congenital deafness and retinitis pigmentosa. It is the most common cause of deafness accompanied by blindness. *There are about 10-15,000 people with Usher syndrome in the United States today and it accounts for 6 percent of the congenitally deaf population and more than 50 percent of the deaf- blind population. While there is currently no medical treatment for Usher syndrome, cochlear implants have been found to be very affective in patients with severe or profound hearing loss.

"Many USH patients benefit from cochlear implants, but preservation and a minimal density of spiral ganglion cells are required for an effective implant," said Zheng.

Spiral ganglion cells are the cells that provide the sense of hearing by sending sound waves from the cochlea to the brain. Dr. Zheng believes residual hair cells in the cochlea could promote the survival of the spiral ganglion neurons by release of neurotrophic substances or growth factors, and as a result he is particularly interested in the discovery of therapeutic targets that prevent hair cell death, as this is the key to helping Usher 1 patients to respond to cochlear implants and other treatment options successfully.

"Hair cell replacement or regeneration therapies have not really solved the deafness problem of ear diseases," said Zheng. "An alternative to replacing lost hair cells is to prevent their loss in the first place."

This grant is Dr. Zheng's fourth NIH grant for research involving auditory disease with accumulated $4 million funding.

"A clear translational goal, expertise of his research team and a very strong publication record, Dr. Zheng has potential to uncover new therapeutic approaches to treat hearing loss in Usher syndrome. I'm very grateful for the NIH for its forward-thinking commitment to Dr. Zheng and his innovative medical science research," said Dr. James Arnold, Julius McCall Professor and Chair of the Department of Otolaryngology Head and Neck Surgery at Case Western Reserve University School of Medicine.

Dr. Zheng aims to: 1) identify the mutation in and characterize a new mouse deafness model (for Usher 1 syndrome and presbycusis or age-related hearing loss) that provides an ideal window of time for evaluating drug therapy; 2) identify key molecules and mechanisms that lead to hair cell death and hearing loss in the models for the Usher 1 syndrome; 3) prove the concept that genetic hearing loss and hair cell death can be prevented by otoprotection therapy.

"We are very honored and pleased that our department has been given this significant award from the NIH," says Dr. Cliff Megerian, Richard W. and Patricia Pogue Professor of Auditory Surgery and Hearing Sciences at University Hospitals Case Medical Center. "The impact of deafness on quality of life and language development is devastating. The financial impact and individual human suffering are devastating, due to the lack of effective drug therapy," adds Dr. Megerian who has collaborated on several research projects with Dr. Zheng.


'/>"/>

Contact: Christina DeAngelis
christinadeangelis@case.edu
216-368-3635
Case Western Reserve University
Source:Eurekalert

Related biology news :

1. The fragility of the worlds coral is revealed through a study of the Northwestern Hawaiian Islands
2. Collaboration leads to success: Most powerful computer of its kind in western N.Y. available worldwide
3. Diabetics on high-fiber diets might need extra calcium, report UT Southwestern researchers
4. Two UT Southwestern researchers awarded Sloan fellowships
5. Antioxidants in Midwestern black raspberries influenced by production site
6. UT Southwestern researchers identify molecule that helps the sleep-deprived to mentally rebound
7. Case Western Reserve researchers develop wireless activation of brain circuits
8. Case Western Reserve researchers looking at light-induced toxins in air and water
9. UT Southwestern researchers disrupt biochemical system involved in cancer, degenerative disease
10. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
11. Climate changes impact on invasive plants in Western US may create restoration opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms ... from 2016 to 2021. The market is estimated to be USD ... by 2021. The growth of the biometric vehicle access system market ...
(Date:12/15/2016)... --  WaferGen Bio-systems, Inc. (NASDAQ: WGBS ... that on December 13, 2016, it received a letter ... Market LLC which acknowledged that, as of December 12, ... had been at $1.00 or greater for ten consecutive ... Rule 5550(a)(2) of the Nasdaq Stock Market. ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Aratana Therapeutics, Inc. (NASDAQ: PETX ... development and commercialization of innovative biopharmaceutical products for companion ... North America 2016. ... on the FDA approval of three innovative therapeutics in ... (capromorelin oral solution) and NOCITA ® (bupivacaine liposome ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017  ArmaGen, ... Mathias Schmidt , Ph.D., as chief executive officer, ... of directors. Dr. Schmidt brings to ArmaGen more than ... the research and development of biotherapeutics and pharmaceuticals. ... executive with the diverse experience and skillset necessary ...
Breaking Biology Technology: